OXALIPLATIN INJECTION, USP
Google image searchProduct monograph
Active ingredient
oxaliplatin, 5 MG/ML
DIN: 02457423
Dosage form(s): SOLUTION
Route(s) of administration: INTRAVENOUS
Schedule: Prescription
Company: FRESENIUS KABI CANADA LTD
Date: 31-MAR-2022
ATC:
- L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
- L01X — OTHER ANTINEOPLASTIC AGENTS (ATC, ATC/DDD)
- L01XA — Platinum compounds (ATC, ATC/DDD)
- L01XA03 — OXALIPLATIN (ATC/DDD)
Reference brand drug: Eloxatin
Pharmaceutical standard: USP
